0001628280-23-041166.txt : 20231208
0001628280-23-041166.hdr.sgml : 20231208
20231208175815
ACCESSION NUMBER: 0001628280-23-041166
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231206
FILED AS OF DATE: 20231208
DATE AS OF CHANGE: 20231208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Waters Kevin
CENTRAL INDEX KEY: 0001653771
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 231476549
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-232-7200
MAIL ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
wk-form4_1702076286.xml
FORM 4
X0508
4
2023-12-06
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001653771
Waters Kevin
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE
SAN JOSE
CA
95134
0
1
0
0
EVP, CFO
1
Common Stock
2023-12-06
4
M
0
4360
4.52
A
37883
D
Common Stock
2023-12-07
4
M
0
3837
4.52
A
41720
D
Common Stock
2023-12-08
4
M
0
6888
4.52
A
48608
D
Common Stock
2023-12-06
4
S
0
4360
40.0214
D
44248
D
Common Stock
2023-12-07
4
S
0
3837
40
D
40411
D
Common Stock
2023-12-08
4
S
0
6888
40.0174
D
33523
D
Stock Option (Right to Buy)
4.52
2023-12-06
4
M
0
4360
0
D
2028-10-22
Common Stock
4360
203357
D
Stock Option (Right to Buy)
4.52
2023-12-07
4
M
0
3837
0
D
2028-10-22
Common Stock
3837
199520
D
Stock Option (Right to Buy)
4.52
2023-12-08
4
M
0
6888
0
D
2028-10-22
Common Stock
6888
192632
D
All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/9/2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0000 to $40.1500, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.0000 to $40.0350, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The Stock Option was granted on October 23, 2018 and vested over a four year period.
/s/ Jonathan Stone, Attorney-in-Fact for Kevin Waters
2023-12-08